1. Home
  2. ANTX vs MLEC Comparison

ANTX vs MLEC Comparison

Compare ANTX & MLEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANTX
  • MLEC
  • Stock Information
  • Founded
  • ANTX 2017
  • MLEC 2008
  • Country
  • ANTX United States
  • MLEC Luxembourg
  • Employees
  • ANTX 36
  • MLEC N/A
  • Industry
  • ANTX Biotechnology: Pharmaceutical Preparations
  • MLEC Blank Checks
  • Sector
  • ANTX Health Care
  • MLEC Finance
  • Exchange
  • ANTX Nasdaq
  • MLEC Nasdaq
  • Market Cap
  • ANTX 40.0M
  • MLEC 33.0M
  • IPO Year
  • ANTX 2022
  • MLEC N/A
  • Fundamental
  • Price
  • ANTX $1.34
  • MLEC $0.90
  • Analyst Decision
  • ANTX Hold
  • MLEC Strong Buy
  • Analyst Count
  • ANTX 5
  • MLEC 1
  • Target Price
  • ANTX $3.50
  • MLEC $6.00
  • AVG Volume (30 Days)
  • ANTX 1.0M
  • MLEC 10.9K
  • Earning Date
  • ANTX 11-13-2024
  • MLEC 12-12-2024
  • Dividend Yield
  • ANTX N/A
  • MLEC N/A
  • EPS Growth
  • ANTX N/A
  • MLEC N/A
  • EPS
  • ANTX N/A
  • MLEC N/A
  • Revenue
  • ANTX N/A
  • MLEC $5,625,124.00
  • Revenue This Year
  • ANTX N/A
  • MLEC $20.42
  • Revenue Next Year
  • ANTX N/A
  • MLEC $30.00
  • P/E Ratio
  • ANTX N/A
  • MLEC N/A
  • Revenue Growth
  • ANTX N/A
  • MLEC 521.53
  • 52 Week Low
  • ANTX $0.87
  • MLEC $0.75
  • 52 Week High
  • ANTX $22.22
  • MLEC $3.25
  • Technical
  • Relative Strength Index (RSI)
  • ANTX 72.02
  • MLEC 56.17
  • Support Level
  • ANTX $0.98
  • MLEC $0.80
  • Resistance Level
  • ANTX $1.46
  • MLEC $0.90
  • Average True Range (ATR)
  • ANTX 0.08
  • MLEC 0.05
  • MACD
  • ANTX 0.03
  • MLEC 0.00
  • Stochastic Oscillator
  • ANTX 75.26
  • MLEC 84.82

About ANTX AN2 Therapeutics Inc.

AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.

About MLEC Moolec Science SA

Moolec Science SA is a science-based ingredient company focused on producing real animal proteins in plants through Molecular Farming, a technology in the alternative protein landscape. Its purpose is to upgrade the taste, nutrition, and affordability of alternative protein products while building a more sustainable and equitable food system. The company has various products in its pipeline such as; TSP Valorasoy which is a soy protein product to produce vegetable proteins with texture and fibrousness similar to those of meat, Glaso, a safflower oil with high levels of gamma-linolenic acid, SPC2 which is a plant-based chymosin, YEEA1, an extract derived from a novel yeast biomass with specific properties, and others. The company's revenues arise from operations in Argentina.

Share on Social Networks: